Drug marketers should appeal to reason during recession

Share this article:
Marketers must appeal less to the emotions and more to ration to woo consumers amid the economic downturn, according to a DDB study. 

“Consumers are not going to be as motivated to take action based solely on higher-order/emotional end benefits in the pharmaceutical, or even in the well—being space,” said Maria Tender, DDB director of brand planning. “Today, more than ever, they will need tangible benefits ascribed to certain brands.”

The survey, by Omnicom's DDB and M/A/R/C Research, found that the value consumers place on health and the time they spend thinking about it increase as incomes dwindle.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Read the complete April 2014 Digital Edition

Read the complete April 2014 Digital Edition

Click the above link to access the complete Digital Edition of the April 2014 issue of MM&M, with all text, charts and pictures.

Antidote: Are e-cigarettes safe?

Antidote: Are e-cigarettes safe?

The pros and cons of e-cigarettes

Combating concept churn

Combating concept churn

There's no cure. But the good news is that prophylaxis is possible.